DJIA 18,080.14 21.45 0.12%
NASDAQ 5,092.09 36.02 0.71%
S&P 500 2,117.69 4.76 0.23%
market minute promo

Celgene (NASDAQ: CELG)

118.71 2.62 (2.26%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

CELG $118.71 2.26%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $115.94
Previous Close $116.09
Daily Range $115.27 - $120.72
52-Week Range $68.38 - $129.06
Market Cap $95.0B
P/E Ratio 48.57
Dividend (Yield) $0.00 (0.0%)
Volume 7,661,352
Average Daily Volume 5,761,290
Current FY EPS $4.42




Drug Makers

Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website:

News & Commentary

3 Mega-Cap Stocks That Shouldn't Pay a Dividend

Mega-cap stocks are generally profitable and overflowing with free cash, leading many to pay handsome dividends. However, these three mega-cap stocks aren't currently paying a dividend -- and if their management teams are smart, they'll keep it that way for many years to come!

Benzinga's Weekend M&A Chatter

Trusty Horses; Tools, Pizza and Shoes: Jim Cramer's Best Blogs

Celgene Signals Bigger Immuno-Oncology Push Into Blood Cancers

AstraZeneca Inks Multiple Deals, Immuno-Oncology in Focus - Analyst Blog

Health Care Sector Update for 04/24/2015: CELG, EHTH, AERI

Why A Bristol-Myers Squibb Bid On Celgene Is Plausible

Jim Cramer Loves Regeneron, Sees Shares Headed to $500

Watch Out: Barbarians At The Gate For Celgene (CELG)

Preview: European Investors Still In Love With North American Equities

See More CELG News...

CELG's Top Competitors

CELG $118.71 (2.26%)
Current stock: CELG
AMGN $167.91 (-0.74%)
Current stock: AMGN
GILD $103.70 (-1.44%)
Current stock: GILD
$0.00 (0.00%)
Current stock: